Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AmpC beta-lactamases producing bacteria].

R Okamoto1, R Nakano

  • 1Department of Microbiology, Kitasato University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Evidence for multi-fragmentation and mass shedding of boulders on rubble-pile binary asteroid system (65803) Didymos.

Nature communications·2024
Same author

Evidence for multi-fragmentation and mass shedding of boulders on rubble-pile binary asteroid system (65803) Didymos.

Nature communications·2024
Same author

Fast boulder fracturing by thermal fatigue detected on stony asteroids.

Nature communications·2024
Same author

Genetic analysis reveals conspecificity of two nominal species of Anaphes fairyflies (Hymenoptera: Mymaridae), egg parasitoids of Oulema leaf beetle (Coleoptera: Chrysomelidae) pests of cereal crops in Europe and of rice in East Asia.

PloS one·2023
Same author

Gastrointestinal: A case of a pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas filling the main pancreatic duct without visible mucin secretion.

Journal of gastroenterology and hepatology·2021
Same author

Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment.

The Journal of hospital infection·2020
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

AmpC beta-lactamases are key to bacterial resistance against beta-lactam antibiotics. This paper reviews their production mechanisms and clinical significance, crucial for combating rising gram-negative bacterial resistance.

Area of Science:

  • Microbiology
  • Biochemistry
  • Genetics

Context:

  • Bacterial resistance to beta-lactam antibiotics is a growing global health concern.
  • AmpC beta-lactamases are a significant contributor to this resistance in gram-negative bacteria.
  • Understanding the genetic location (chromosomal vs. plasmid) of AmpC beta-lactamase genes is critical.

Purpose:

  • To elucidate the general mechanisms underlying AmpC beta-lactamase production.
  • To discuss the clinical importance and implications of AmpC beta-lactamase enzymes.
  • To provide a comprehensive overview of AmpC beta-lactamase-mediated resistance.

Summary:

  • Beta-lactamases, particularly AmpC variants, are the primary cause of bacterial resistance to beta-lactam antibiotics.
  • The prevalence of extended-spectrum beta-lactamases, carbapenemases, and AmpC beta-lactamases is increasing alarmingly in clinical gram-negative bacterial isolates.

Related Experiment Videos

  • AmpC beta-lactamases are categorized based on whether their genes are located on the chromosome or plasmids.

    • Impact:

    • Informing therapeutic strategies against resistant gram-negative infections.
    • Guiding the development of new antimicrobial agents and diagnostic tools.
    • Highlighting the urgent need for effective control of AmpC beta-lactamase-mediated resistance in clinical settings.